MDxHealth SA (MDXH)
0.6972
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 16:00
0.6972
0.00 (0.00%)
After-Hours: 17:45
MDxHealth Enterprise Value : 123.29M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 123.29M |
| September 04, 2026 | 125.08M |
| September 03, 2026 | 123.94M |
| September 02, 2026 | 123.11M |
| September 01, 2026 | 123.64M |
| August 31, 2026 | 123.63M |
| August 28, 2026 | 123.66M |
| August 27, 2026 | 123.70M |
| August 26, 2026 | 125.48M |
| August 25, 2026 | 127.16M |
| August 24, 2026 | 124.72M |
| August 21, 2026 | 124.81M |
| August 20, 2026 | 123.62M |
| August 19, 2026 | 125.63M |
| August 18, 2026 | 125.22M |
| August 17, 2026 | 130.59M |
| August 14, 2026 | 128.14M |
| August 13, 2026 | 110.37M |
| August 12, 2026 | 110.76M |
| August 11, 2026 | 109.30M |
| August 10, 2026 | 109.96M |
| August 07, 2026 | 110.32M |
| August 06, 2026 | 109.14M |
| August 05, 2026 | 108.91M |
| August 04, 2026 | 109.34M |
| Date | Value |
|---|---|
| August 03, 2026 | 110.01M |
| July 31, 2026 | 108.11M |
| July 30, 2026 | 107.58M |
| July 29, 2026 | 107.20M |
| July 28, 2026 | 107.75M |
| July 27, 2026 | 108.11M |
| July 24, 2026 | 107.70M |
| July 23, 2026 | 108.33M |
| July 22, 2026 | 109.08M |
| July 21, 2026 | 108.37M |
| July 20, 2026 | 108.04M |
| July 17, 2026 | 108.36M |
| July 16, 2026 | 108.50M |
| July 15, 2026 | 109.19M |
| July 14, 2026 | 107.96M |
| July 13, 2026 | 108.73M |
| July 10, 2026 | 111.09M |
| July 09, 2026 | 111.80M |
| July 08, 2026 | 112.06M |
| July 07, 2026 | 110.71M |
| July 06, 2026 | 111.46M |
| July 02, 2026 | 111.11M |
| July 01, 2026 | 112.68M |
| June 30, 2026 | 107.73M |
| June 29, 2026 | 83.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 399.31M |
| BioRestorative Therapies, Inc. | 0.013M |
| CareDx, Inc. | 2.236B |
| Natera, Inc. | 45.70B |
| Exagen, Inc. | 179.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.478M |
| Revenue (Quarterly) | 27.21M |
| Total Expenses (Quarterly) | 36.69M |
| EPS Diluted (Quarterly) | -0.2245 |
| Gross Profit Margin (Quarterly) | 61.13% |
| Profit Margin (Quarterly) | -34.83% |
| Earnings Yield | -105.1% |
| Normalized Earnings Yield | -105.13 |